# Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

> **NCT01605370** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 1 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Metoprolol succinate

## Key facts

- **NCT ID:** NCT01605370
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Difficulty in identifying subjects satisfying the inclusion criteria.
- **Last updated:** 2014-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605370, "Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01605370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*